Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,427 public trials 1,034 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Safety and Efficacy Study of TRU-016 Plus Bendamustine vs. Bendamustine in Relapsed Chronic Lymphocytic Leukemia

NCT01188681

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • For additional information regarding sites for this trial call (919) 465-4648 Denver, Colorado, United States
  • For additional information regarding sites for this trial call (919) 465-4648 Augusta, Georgia, United States
  • For additional information regarding sites for this trial call (919) 465-4648 Chicago, Illinois, United States
  • For additional information regarding sites for this trial call (919) 465-4648 Hackensack, New Jersey, United States
View all 25 locations
View Trial Details
Completed

A Dose-Ranging Study of IV BNZ-1 in LGL Leukemia or Refractory CTCL

NCT03239392

Conditions
CTCL, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The James Cancer Center, Ohio State University Columbus, Ohio, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details
Completed

Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain

NCT03435341

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • Hospital de Jerez Jerez de la Frontera, Andalucía/Cádiz, Spain
  • Hospital Virgen de las Nieves Granada, Andalucía/Granada, Spain
  • Hospital Carlos Haya Málaga, Andalucía/Málaga, Spain
  • Hospital Virgen del Rocio Seville, Andalucía/Sevilla, Spain
View all 40 locations
View Trial Details
Completed

Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)

NCT02669017

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +27 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • II. Medizinische Klinik Aschaffenburg, Germany
View all 174 locations
View Trial Details
Completed

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00053768

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Specialist Practice for Oncology Aschaffenburg, Germany
View all 175 locations
View Trial Details
Completed

Safety and Efficacy of Two Doses of ATIR101, a T-lymphocyte Enriched Leukocyte Preparation Depleted of Host Alloreactive T-cells, in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor

NCT02500550

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +18 more
Locations
  • Algemeen Ziekenhuis Sint-Jan Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • Universitair Ziekenhuis Gasthuisberg Leuven, Belgium
  • Centre Hospitalier Universitaire de Liège Liège, Belgium
View Trial Details

Related conditions